investment

Photo

Perstorp Opens New Penta Plant in India

Sweden-based specialty chemicals company Perstorp has built and commissioned a new ISCC Plus-certified plant in western India to meet the growing market demand for Penta chemicals.

Photo

Air Liquide and Dow Renew Supply Deal for German Site

Air Liquide and Dow renewed their industrial gas supply agreement for Dow’s chemical production site in Stade, Germany. Under the long-term agreement, Air Liquide will supply industrial gases and invest almost €40 million in modernizing its facilities to increase operational efficiency and reduce CO₂ emissions.

Photo

AstraZeneca to Construct New US Cell Therapy Facility

In a move to launch its cell therapy platforms for critical cancer trials in the US, AstraZeneca is investing $300 million in a new facility in Rockville, Maryland. The site will initially focus on the production of T-cell therapies, with the possibility of supporting other disease areas in the future.

Photo

Brenntag Acquires a Chemical Logistics Site in Italy

Brenntag announced the agreement to acquire a chemical logistics site of Chimica D’Agostino in Italy. The site is located in the industrial area of the city of Bari, well connected with Adriatic highway, and with easy access to harbours on the seaside.

Photo

AbbVie to Build New Biologics Manufacturing Site in Singapore

Last week, AbbVie broke ground on a new Singapore manufacturing facility located in Singapore's Tuas Biomedical Park. The company will invest $223 million in the site which will add 24,000 l of biologics drug-substance capacity to AbbVie's global manufacturing network and support current products as well as emerging immunology and oncology compounds within its pipeline.

Photo

Gedeon Richter Becomes Strategic Investor of Formycon

Hungary-headquartered specialty pharmaceutical company Gedeon Richter becomes a strategic investor of German biosimilars company Formycon via cash capital increase of 9.08% of Formycon’s share capital, which corresponds to €82.84 million.

Photo

Olon to Open New High Potency API Suite in US

Olon Group is building a state-of-the-art High Potency Active Pharmaceutical Ingredient (HPAPI) suite at its Olon USA site in Concord, Ohio. This expands the company's capabilities for handling HPAPI, with investments totaling around €40 million ($43 million) in recent years.

Photo

Boehringer to Expand Greek Production Site for New Medicines

German drugmaker Boehringer Ingelheim is investing €120 million in an upgrade and expansion of its facility in Koropi, Greece, that will increase the company's capacity to produce existing and new medicines. Main disease areas, Boehringer said, include cardio-renal-metabolic (CRM) diseases, mental health, and pulmonary fibrosis.

Photo

Solenis to Expand in Virginia

Solenis to invest €176 million ($193 million) in City of Suffolk facility expansion. The company will build a new 7430-square-meter (80,000-square-foot) production facility, packaging facility, and tank farm. This new facility will be used to grow the existing polymer product line and add additional capacity of this critical monomer to the existing supplier.

Photo

Arkema Acquires a Stake in Battery Start-up Tiamat

French chemical producer Arkema announced that it will become a shareholder of Tiamat, a start-up that designs, develops, industrializes and markets sodium-ion batteries, a new lithium-free technology. Tiamat was spun off from the Centre National de la Recherche Scientifique (CNRS) in 2017.

Photo

Sumitomo Starts up New CO2-to-Methanol Pilot Plant

Japan’s Sumitomo Chemical has completed the construction of a pilot facility using a highly efficient process for producing methanol from CO2 at its Ehime Works facility, located in Niihama City, Ehime Prefecture, Japan, and has started operations at the facility.

Photo

BASF Completes Geismar Specialty Amines Expansion

BASF has completed its capacity expansion for key specialty amines manufactured at its US site in Geismar, Louisiana. The project, announced in June 2022, allows the company to increase production of polyetheramines and amine catalysts marketed under the Baxxodur and Lupragen brands.

Photo

Elementis Plans New R&D Unit in Portugal

UK’s Elementis, a global specialty chemicals company, will be opening a new unit in Portugal, featuring a center of excellence and R&D laboratory. The new unit, which will be headquartered in Porto and is scheduled to open in the first half of 2024, will support the company’s business segments Personal Care and Performance Specialties and also reinforce the current R&D capacity of the Elementis' laboratories in Asia and the Americas.

Photo

Novo Nordisk to Invest €2.1 Billion in French Production Site

Novo Nordisk wants to make another major capital investment in production capacity for its diabetes and obesity therapies. The Danish drugmaker announced to spend more than 16 billion Danish kroner (€2.1 billion euros) starting in 2023 to expand its production site in Chartres, France, adding aseptic production and finished production processes and an extension of the current Quality Control Laboratory.

Photo

Ineos and Sinopec Open New ABS Facility in China

Ineos Styrolution, a styrenics producer, has opened a new world-scale ABS (acrylonitrile butadiene styrene) facility located in Ningbo, China, together with its joint venture partner Sinopec. The facility has an annual nameplate capacity of 600,000 tons.

Photo

Brenntag Supports Energy Sector with New US Site in Louisiana

German chemicals and ingredients distributor Brenntag has opened its new facility in Maurice, Louisiana, USA. Strategically positioned along the US Gulf Coast, the new site will be the primary operations hub for Coastal Chemical, a subsidiary of Brenntag, in addition to serving other areas in the region, the company said.

Photo

AkzoNobel to Build Facility for Bisphenol-Free Coatings in Spain

AkzoNobel is investing €32 million in a new plant at its Vilafranca site in Spain, which will produce bisphenol-free coatings for the metal packaging industry in Europe, Middle East and Africa (EMEA). AkzoNobel expects facility to be operational by mid-2025 and to create around 40 jobs.

153 more articles

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.